Exploring the Potential Mechanism of Ru-Pi-Ning Granules Against Mammary Gland Hyperplasia Based on UPLC-Q-TOF-MS and Network Pharmacology.

Ru-Pi-Ning granules were a classic traditional Chinese medicine (TCM) prescription with good therapeutic effects on mammary gland hyperplasia (MGH). However, the main components and potential mechanisms of action of Ru-Pi-Ning were still unclear. This study aimed to preliminarily elucidate the potential mechanism of Ru-Pi-Ning in the treatment of MGH based on ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) and network pharmacology. Compounds in Ru-Pi-Ning were determined by UPLC-Q-TOF-MS. A Venn diagram was created with drug targets and disease targets, and a PPI network diagram was constructed with shared targets using the STRING database. GO and KEGG pathway analysis were performed using the Metascape platform; molecular docking was carried out using AutoDockTools. A total of 127 active components and 75 overlapping genes were screened out. The main biological processes included cellular response to hormone stimulus and positive regulation of cell migration. Ru-Pi-Ning in treating MGH could regulate several signaling pathways, including the relaxin-signaling pathway and HIF-1 signaling pathway. The core targets were TP53, EGFR, and AKT1. Molecular docking indicated that the active compounds had good binding ability with the screened targets. Ru-Pi-Ning might exert its therapeutic effect on MGH through multiple components, multiple targets, and multiple pathways.

• Publication year

  2026

• Venue

  Biomedical chromotography

• Publication date

  2026-01-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/bmc.70356PMID 41549505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of relaxin signaling in Cancer: A review.

  2024cited by this paper
• TNF-α induced NF-κB mediated LYRM7 expression modulates the tumor growth and metastatic ability in breast cancer.

  2023cited by this paper
• Genkwanin: An emerging natural compound with multifaceted pharmacological effects.

  2023cited by this paper
• [Research progress on traditional Chinese medicine compounds combined with external therapy in treatment of hyperplasia of mammary glands].

  2023cited by this paper
• The dual and multifaceted role of relaxin-2 in cancer

  2023cited by this paper
• Construction of microneedle of Atractylodes macrocephala Rhizoma aqueous extract and effect on mammary gland hyperplasia based on intestinal flora

  2023cited by this paper
• Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula.

  2023cited by this paper
• Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.

  2023cited by this paper
• [Mechanism of blood-activating and mass-dissipating Chinese patent medicine against hyperplasia of mammary glands and use with other medicine: a review].

  2023cited by this paper
• Proteoglycans in breast cancer, identification and characterization by LC‐MS/MS assisted proteomics approach: A review

  2023cited by this paper
• CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS

  2023cited by this paper
• Review of Mammary Gland Hyperplasia in Classical Chinese Medical Literature.

  2023cited by this paper
• Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway.

  2023cited by this paper
• The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms

  2023cited by this paper
• [Mechanism of anti-hyperplasia of mammary glands of Xihuang Pills blood-entering component based on UPLC-Q-TOF-MS and network pharmacology].

  2023cited by this paper
• Correction for Liu et al., HIF-1–regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation

  2022cited by this paper
• Health Benefits of Quercetin in Age-Related Diseases

  2022cited by this paper
• Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer

  2022cited by this paper
• Value and influencing factors of valid Traditional Chinese Medicine compound prescription patents for mammary gland hyperplasia.

  2022cited by this paper
• Tamoxifen in mastalgia: A meta-analysis.

  2022cited by this paper
• Quercetin attenuates sepsis-induced acute lung injury via suppressing oxidative stress-mediated ER stress through activation of SIRT1/AMPK pathways.

  2022cited by this paper
• TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study

  2021cited by this paper
• Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target

  2021cited by this paper
• The DisGeNET cytoscape app: Exploring and visualizing disease genomics data

  2021cited by this paper
• AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings

  2021cited by this paper
• Clinical practice guideline for diagnosis and treatment of hyperplasia of the mammary glands: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021

  2021cited by this paper
• HIF-1–regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation

  2021cited by this paper
• Dose-Dependent Effects of Royal Jelly on Estrogen- and Progesterone-Induced Mammary Gland Hyperplasia in Rats.

  2021cited by this paper
• RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences

  2020cited by this paper
• Massage treatment of hyperplasia of mammary glands

  2020cited by this paper
• Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs

  2020cited by this paper
• Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer

  2020cited by this paper
• Isorhamnetin: A review of pharmacological effects.

  2020cited by this paper
• Determination of isosinensetin in rat plasma by UHPLC-MS/MS: Application to oral and intravenous pharmacokinetic study in healthy rats.

  2020cited by this paper
• The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches

  2020cited by this paper
• Tamoxifen-induced vasculitis

  2020cited by this paper
• The DisGeNET knowledge platform for disease genomics: 2019 update

  2019cited by this paper
• The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer.

  2019cited by this paper
• Distinct functions of AKT isoforms in breast cancer: a comprehensive review

  2019cited by this paper
• Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells

  2018cited by this paper
• Database resources of the National Center for Biotechnology Information

  2017cited by this paper
• Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach.

  2017cited by this paper
• DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants

  2016cited by this paper
• DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes

  2015cited by this paper
• Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogen-activated protein kinase kinase signaling pathways

  2015cited by this paper
• TCMSP: a database of systems pharmacology for drug discovery from herbal medicines

  2014cited by this paper
• A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention.

  2013cited by this paper
• GeneCards Version 3: the human gene integrator

  2010cited by this paper

• No citing papers are available for this paper.